The tumor suppressor miR-124 inhibits cell proliferation by targeting STAT3 and functions as a prognostic marker for postoperative NSCLC patients

International Journal of Oncology

Volumn 46, Issue 2, 2015, Pages 798-808

  Li, Xiumei ^a   Yu, Zhuang ^a   Li, Yong ^a   Liu, Shihai ^a   Gao, Caihong ^a   Hou, Xin ^a   Yao, Ruyong ^a   Cui, Lianhua ^b  

^a QINGDAO UNIVERSITY   (China)

^b QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

MiR 124; Non small cell lung cancer; Prognosis; STAT3

Indexed keywords

MICRORNA 124; MUTANT PROTEIN; STAT3 PROTEIN; MICRORNA; MIRN124 MICRORNA, HUMAN; STAT3 PROTEIN, HUMAN;

3' UNTRANSLATED REGION; A549 CELL LINE; ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DOWN REGULATION; FEMALE; FOLLOW UP; GENE OVEREXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; REAL TIME POLYMERASE CHAIN REACTION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; APOPTOSIS; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; LYMPH NODE; MIDDLE AGED; PATHOLOGY; PROGNOSIS;

ADULT; AGED; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LYMPH NODES; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; STAT3 TRANSCRIPTION FACTOR;

EID: 84918572981     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2014.2786     Document Type: Article

References (42)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011.
2. Herbst RS, Heymach JV and Lippman SM: Lung cancer. N Engl J Med 359: 1367-1380, 2008.
3. Calin GA, Sevignani C, Dumitru CD, et al: Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci USA 101: 2999-3004, 2004.
4. Johnson CD, Esquela-Kerscher A, Stefani G, et al: The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67: 7713-7722, 2007.
5. Kumar MS, Erkeland SJ, Pester RE, et al: Suppression of non-small cell lung tumor development by the let-7 microRNA family. Proc Natl Acad Sci USA 105: 3903-3908, 2008.
6. Takamizawa J, Konishi H, Yanagisawa K, et al: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64: 3753-3756, 2004.
7. Lin PY, Yu SL and Yang PC: MicroRNA in lung cancer. Br J Cancer 103: 1144-1148, 2010.
8. Liu J, Carmell MA, Rivas FV, et al: Argonaute2 is the catalytic engine of mammalian RNAi. Science 305: 1437-1441, 2004.
9. Ambros V: The functions of animal microRNAs. Nature 431: 350-355, 2004.
10. Croce CM: Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10: 704-714, 2009.
11. Liu X, Sempere LF, Galimberti F, et al: Uncovering growthsuppressive MicroRNAs in lung cancer. Clin Cancer Res 15: 1177-1183, 2009.
12. Ando T, Yoshida T, Enomoto S, et al: DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int J Cancer 124: 2367-2374, 2009.
13. Shimizu T, Suzuki H, Nojima M, et al: Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer. Eur Urol 63: 1091-1100, 2013.
14. Lv XB, Jiao Y, Qing Y, et al: miR-124 suppresses multiple steps of breast cancer metastasis by targeting a cohort of pro-metastatic genes in vitro. Chin J Cancer 30: 821-830, 2011.
15. Zhang J, Lu Y, Yue X, et al: MiR-124 suppresses growth of human colorectal cancer by inhibiting STAT3. PLoS One 8: e70300, 2013.
16. Wei J, Wang F, Kong LY, et al: miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma. Cancer Res 73: 3913-3926, 2013.
17. Grivennikov SI and Karin M: Dangerous liaisons: STAT3 and NF-kappaB collaboration and crosstalk in cancer. Cytokine Growth Factor Rev 21: 11-19, 2010.
18. Zhang X, Zhang J, Wang L, Wei H and Tian Z: Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice. BMC Cancer 7: 149, 2007.
19. Kanda N, Seno H, Konda Y, et al: STAT3 is constitutively activated and supports cell survival in association with survivin expression in gastric cancer cells. Oncogene 23: 4921-4929, 2004.
20. Yang G, Huang C, Cao J, Huang KJ, Jiang T and Qiu ZJ: Lentivirus-mediated shRNA interference targeting STAT3 inhibits human pancreatic cancer cell invasion. World J Gastroenterol 15: 3757-3766, 2009.
21. Ikari A, Sato T, Watanabe R, Yamazaki Y and Sugatani J: Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells. Biochim Biophys Acta 1823: 1110-1118, 2012.
22. Peltier HJ and Latham GJ: Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA 14: 844-852, 2008.
23. Howington JA, Blum MG, Chang AC, Balekian AA and Murthy SC: Treatment of stage I and II non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 143: e278S-313S, 2013.
24. Raveche ES, Salerno E, Scaglione BJ, et al: Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. Blood 109: 5079-5086, 2007.
25. Hatley ME, Patrick DM, Garcia MR, et al: Modulation of K-Rasdependent lung tumorigenesis by MicroRNA-21. Cancer Cell 18: 282-293, 2010.
26. Clark AM, Goldstein LD, Tevlin M, Tavare S, Shaham S and Miska EA: The microRNA miR-124 controls gene expression in the sensory nervous system of Caenorhabditis elegans. Nucleic Acids Res 38: 3780-3793, 2010.
27. Fowler A, Thomson D, Giles K, et al: miR-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer 47: 953-963, 2011.
28. Li KK, Pang JC, Ching AK, et al: miR-124 is frequently downregulated in medulloblastoma and is a negative regulator of SLC16A1. Hum Pathol 40: 1234-1243, 2009.
29. Lv Z and Yang L: MiR-124 inhibits the growth of glioblastoma through the downregulation of SOS1. Mol Med Rep 8: 345-349, 2013.
30. Zheng F, Liao YJ, Cai MY, et al: The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2. Gut 61: 278-289, 2012.
31. Hatziapostolou M, Polytarchou C, Aggelidou E, et al: An HNF4alpha-miRNA inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell 147: 1233-1247, 2011.
32. Han ZB, Yang Z, Chi Y, et al: MicroRNA-124 suppresses breast cancer cell growth and motility by targeting CD151. Cell Physiol Biochem 31: 823-832, 2013.
33. Wang P, Chen L, Zhang J, et al: Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1. Oncogene 33: 514-524, 2014.
34. Zhao WH, Wu SQ and Zhang YD: Downregulation of miR-124 promotes the growth and invasiveness of glioblastoma cells involving upregulation of PPP1R13L. Int J Mol Med 32: 101-107, 2013.
35. Haura EB, Turkson J and Jove R: Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer. Nat Clin Pract Oncol 2: 315-324, 2005.
36. Yu H, Pardoll D and Jove R: STATs in cancer inflammation and immunity: a leading role for STAT3. Nat Rev Cancer 9: 798-809, 2009.
37. Lu Y, Yue X, Cui Y, Zhang J and Wang K: MicroRNA-124 suppresses growth of human hepatocellular carcinoma by targeting STAT3. Biochem Biophys Res Commun 441: 873-879, 2013.
38. Li Y, Zhang Z, Liu X, et al: miR-124 functions as a tumor suppressor in the endometrial carcinoma cell line HEC-1B partly by suppressing STAT3. Mol Cell Biochem 388: 219-231, 2014.
39. Wang MJ, Li Y, Wang R, et al: Downregulation of microRNA- 124 is an independent prognostic factor in patients with colorectal cancer. Int J Colorectal Dis 28: 183-189, 2013.
40. Gebauer K, Peters I, Dubrowinskaja N, et al: Hsa-mir-124-3 CpG island methylation is associated with advanced tumours and disease recurrence of patients with clear cell renal cell carcinoma. Br J Cancer 108: 131-138, 2013.
41. Berghmans T, Ameye L, Willems L, et al: Identification of microRNA-based signatures for response and survival for non-small cell lung cancer treated with cisplatin-vinorelbine A ELCWP prospective study. Lung Cancer 82: 340-345, 2013.
42. Patnaik SK, Kannisto E, Knudsen S and Yendamuri S: Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Cancer Res 70: 36-45, 2010.